Video
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
FDA approves prednisolone acetate ophthalmic suspension for treating steroid-responsive ocular inflammation
3 Things You Should Know About Interventional Glaucoma Comanagement
Formosa Pharmaceuticals grants Harrow US commercial rights to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Zeteo Biomedical secures US and EU patents for drug delivery technologies
NIH study identifies brain circuits critical to visual acuity beyond the retina